Medicare Rx and the Sequester Impact: Making Headlines, But is There a Commercial Impact?
This article was originally published in RPM Report
Executive Summary
Two large pharmaceutical manufacturers weigh in on whether the sequester is impacting their injectables business. The answer so far: not really. The same story goes for the sequester and Part D, though Lilly is seeing higher than expected Part D discounts in 2013.